Normal values of insulin-like growth factor I and their clinical utility in adults

被引:37
作者
Strasburger, CJ [1 ]
Bidlingmaier, M [1 ]
Wu, ZD [1 ]
Morrison, KM [1 ]
机构
[1] Univ Munich, Dept Med, Neuroendocrine Unit, D-80336 Munich, Germany
关键词
acromegaly; acid-labile subunit; diagnosis; growth hormone deficiency; insulin-like growth factor I; insulin-like growth factor binding protein 3 monitoring; normative data; safety;
D O I
10.1159/000063484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration Of circulating insulin-like growth factor I (IGF-I) is a potential marker for growth hormone (GH) deficiency in adults. Indeed, researchers have shown that IGF-I levels are of greater diagnostic value than other possible markers, Such as IGF-binding protein 3 (IGFBP-3) and the acid-labile subunit (ALS). Accurate age-matched normative data are essential to give patient data diagnostic meaning. Such data are assay specific and must exclude those individuals with certain confounding medical conditions. Post-diagnosis, monitoring of IGF-I and IGFBP-3 levels can be used to assess the efficacy and safety of GH replacement therapy. Furthermore, IGF-I levels, and possibly ALS levels, can be used to aid the diagnosis and monitoring of acromegaly. For example, acromegaly can be excluded in patients with normal. IGF-I levels if liver failure and malnutrition/malabsorption are ruled out. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 50 条
  • [31] Acromegaly and serum insulin-like growth factor I
    Thorner, MO
    HORMONE RESEARCH, 2004, 62 : 34 - 36
  • [32] Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer
    Han, Lu
    Zhang, Guo-Feng
    Cheng, Yue-Hu
    Zhao, Qi-Cheng
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1127 - 1134
  • [33] INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 IN TAIWANESE WOMEN DURING NORMAL-PREGNANCY
    WANG, HS
    CHENG, BJ
    SOONG, YK
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1995, 94 (11) : 698 - 701
  • [34] EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I ADMINISTRATION IN ADULTS WITH GROWTH-HORMONE DEFICIENCY
    THOREN, M
    WIVALLHELLERYD, IL
    HALL, K
    ACTA PAEDIATRICA, 1993, 82 : 45 - 48
  • [35] Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women
    Lavigne, JA
    Baer, DJ
    Wimbrow, HH
    Albert, PS
    Brown, ED
    Judd, JT
    Campbell, WS
    Giffen, CA
    Dorgan, JF
    Hartman, TJ
    Barrett, JC
    Hursting, SD
    Taylor, PR
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 81 (02) : 503 - 507
  • [36] Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency
    Clemmons, DR
    HORMONE RESEARCH, 2001, 55 : 73 - 79
  • [37] Growth hormone, insulin-like growth factor I, and motoneuron size
    Chen, L
    Lund, PK
    Burgess, SB
    Rudisch, BE
    McIlwain, DL
    JOURNAL OF NEUROBIOLOGY, 1997, 32 (02): : 202 - 212
  • [38] Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia
    Roberts, RO
    Jacobson, DJ
    Girman, CJ
    Rhodes, T
    Klee, GG
    Lieber, MM
    Jacobsen, SJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (09) : 784 - 791
  • [39] Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis?
    Chanson, Philippe
    Maison, Patrick
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (02): : 70 - 71
  • [40] Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteins
    Mauras, N
    Quarmby, V
    Bloedow, DC
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (04): : E579 - E584